AMNEAL PHARMACT Balance Sheet - Annual (NYSE:AMRX)

Add to My Stocks
$23.8 $0.34 (1.45%) AMRX stock closing price Sep 19, 2018 (Closing)
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Cash181.77M180.13M340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M
Marketable Securities---199.98M228.52M156.75M241.99M256.6M58.59M50.71M
Receivables301.95M257.36M324.45M146.49M112.99M92.24M153.77M82.05M185.85M43.3M
Inventory158.47M175.23M125.58M80.57M70.1M89.76M54.17M44.54M49.13M32.3M
Raw Materials51.23M41.07M38.85M23.02M21.25M24.8M24.18M21.42M29.31M14.4M
Work In Progress3.04M3.28M4.41M2.44M1.43M4M5.04M2.57M2.76M1.39M
Finished Goods104.18M130.87M82.31M55.1M47.41M60.95M24.94M20.54M17.05M16.5M
Notes Receivable----------
Other Current Assets53.35M18.41M31.68M88.53M63.5M64.61M45.57M45.69M48.65M40.87M
Total Current Assets
695.55M631.14M822.07M730.45M659.74M545.54M599.93M520.69M374.01M236.46M
Property Plant & Equipment240.42M389.68M347.3M304.35M287.81M267.52M192.95M168.92M151.96M135.31M
Accumulated Depreciation115.6M156.31M133.14M116.18M99.62M86.76M74.8M62.64M50.31M39.68M
Net Property Plant & Equipment
124.81M233.37M214.15M188.16M188.19M180.75M118.15M106.28M101.65M95.62M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges-69.86M-41.83M33.92M19.39M7.43M13.29M145.16M145.74M
Intangibles469.79M827.79M812.18M54.28M57.24M75.52M27.57M27.57M27.57M27.57M
Deposits & Other Assets61.13M60.84M73.75M64.45M57.82M42.75M40.75M25.47M12.35M9.16M
Total Assets
1.35B1.82B1.92B1.08B996.92M863.97M793.85M693.31M660.75M514.58M
Notes Payable----------
Accounts Payable81.09M58.95M56.32M31.97M26.82M41.34M22.95M18.81M23.29M12.79M
Current Portion Long-Term Debt17.84M17.71M-------14.65M
Current Portion Capital Leases----------
Accrued Expenses248.12M244.65M270.43M125.81M123.08M97.67M110.88M89.32M147.37M47.36M
Income Taxes Payable----------
Other Current Liabilities7.17M---3.98M6.27M23.02M18.27M33.19M35.01M
Total Current Liabilities
354.23M321.32M326.76M158.69M153.89M145.29M156.86M126.41M203.86M109.82M
Mortgages----------
Deferred Taxes/Income3.22M-72.77M3.4M4.26M6.36M17.13M44.19M224.52M225.8M
Convertible Debt----------
Long-Term Debt769.52M813.54M424.59M------5.99M
Non-Current Capital Leases----------
Other Long-Term Liabilities37.11M64.17M35.95M29.21M28.56M21.21M16.86M14.55M10.13M13.56M
Total Liabilities
1.16B1.2B860.07M191.32M186.72M172.86M190.85M185.16M438.52M355.18M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus559.63M535.05M504.07M364.1M336.64M314.71M285.96M255.44M223.23M203.53M
Retained Earnings-372.44M98.19M570.22M531.22M473.87M372.61M316.74M251.24M--41.59M
Treasury Stock2.15M2.15M2.15M2.15M2.15M2.15M2.15M2.15M2.15M2.15M
Other Liabilities1.42M-7.85M-10.46M-6M1.14M5.24M1.78M2.97M-0.3M-0.99M
Shareholders Equity187.2M623.97M1.06B887.87M810.2M691.1M603M508.14M222.22M159.39M
Total Liabilities & Shareholders Equity1.35B1.82B1.92B1.08B996.92M863.97M793.85M693.31M660.75M514.58M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

AMNEAL PHARMACT Balance Sheet - Key Ratios

Current ratio
2.01
Debt to equity ratio
2.96
Asset turnover ratio
0.57
Receivables turnover
2.8
Price to book ratio
6.9